Patents Assigned to PROLEVI BIO AB
  • Compositions for modified release of active ingredients
    Patent number: 12778895
    Abstract: The present disclosure relates to the field of sustained release compositions of active ingredients able to modulate endocrine or hormonal signalling and uses thereof. The formulations according to the present disclosure accommodate for chronotherapeutic events of fluctuating levels natural in signalling over a 24 hour period.
    Type: Grant
    Filed: April 20, 2023
    Date of Patent: November 3, 2026
    Assignee: PROLEVI BIO AB
    Inventors: Sahil Gupta, Daniel Bar-Shalom